Aromaterapi Uygulamasının Demanslı Bireylerde Görülen Davranışsal Değişiklikler Üzerine Etkisi
Öz
Anahtar Kelimeler
Kaynakça
- Akhondzadeh, S., Noroozian, M., Mohammadi, M.
- Ohadinia, S., Jamshidi, A.H., Khani M. (2003). Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer’s disease: a double blind, randomised, placebo controlled trial. Journal of Neurology Neurosurgery and Psychiatry, 74, 863–866.
- Alzheimer Europe. (2012). The prevalence of dementia in Europe for Turkey. Erişim: 03.02.2015.
- http://www.alzheimer-europe.org/Policy-in Practice2/Country dementia-in-Europe/Turkey
- Amerikan Alzheimer Derneği (American Azheimer’s Association). (2014). Alzheimer’s disease facts and figures, Alzheimer’s & Dementia, Volume 10, Issue 2.
- Ballard, C. G., O’Brien, J. T., James, I., Mynt, P., Lana, M., Potkins, D. et al. (2001). Quality of life for people with dementia living in residental and nursing home care: the impact of performance on activities of daily living, behavioral and psychological symptoms, language skills and psychotropic drugs. International Psychogeriatrics, 13, 93- 106.
- Ballard, C. G., O’Brien, J. T., Reichelt, K., Perry, E. K. (2002). Aromatherapy as a safe of a double-blind, placebo-controlled trial with Melissa. Journal of Clinical Psychiatry, 63, 553–558.
- Barlett, H., Gray, L., Byrne, G., Travers, C., Lui, C. (2006), Dementia a national health priority, dementia research mapping project final report. Commonwealth Department of Health and Ageing, Queensland, Australia. 82-101.
Ayrıntılar
Birincil Dil
Türkçe
Konular
-
Bölüm
-
Yayımlanma Tarihi
1 Ağustos 2015
Gönderilme Tarihi
-
Kabul Tarihi
-
Yayımlandığı Sayı
Yıl 2015 Cilt: 8 Sayı: 3
